EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior

Sounak Gupta, Lynette M Sholl, Yiying Yang, Adeboye O Osunkoya, Jennifer B Gordetsky, Kristine M Cornejo, Kvetoslava Michalova, Fiona Maclean, Eugénia Dvindenko, Matija Snuderl iD, Michelle S Hirsch, William J Anderson und 9 weitere

The Journal of Pathology · 2024-01 · 262 (1) · 50-60

DOI: 10.1002/path.6210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2024-01. Verfasst von Sounak Gupta und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Seminoma, Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Biological Products. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Pathology of Brigham, Women's Hospital and Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spermatocytic tumor (ST) is a rare type of germ cell tumor that occurs exclusively in the postpubertal testis and typically affects elderly men. Most STs are benign, but rare cases exhibit aggressive clinical behavior, often in association with transition to sarcomatoid histology. Limited molecular analyses have been performed on STs; therefore, their genomic and epigenomic features remain incompletely described. Twenty‐seven samples from 25 individual patients were analyzed with a combination of DNA sequencing panels, genomic methylation profiling, SNP array, isochromosome (12p) [i(12p)] FISH, and immunohistochemistry. The series included five metastasizing tumors (three with sarcomatoid transformation, one anaplastic, and one conventional) and 20 non‐metastasizing tumors (14 anaplastic and six conventional). Anaplastic tumors comprised a monomorphic population of intermediate‐sized neoplastic cells, as previously described. Multiomic analyses demonstrated that there were two genomic subgroups of STs: one with diploid genomes and hotspot RAS / RAF variants and the other with global ploidy shift and absence of recurrent mutations. Relative gain of chromosome 9 was a consistent finding in both subgroups. A comparison of metastasizing and non‐metastasizing cases demonstrated that aggressive behavior was associated with the acquisition of pathogenic TP53 mutations and/or relative gains of 12p/i(12p). In cases with sarcomatoid transformation, TP53 mutations seem to underlie the transition to sarcomatoid histology. Genomic methylation analysis demonstrated that aggressive cases with gains of 12p cluster closer to pure seminomas than to STs without gains of 12p. In conclusion, STs include two genomic subgroups, characterized by global ploidy shifts without recurrent mutations and diploid genomes with RAS / RAF hotspot mutations, respectively. Biologic progression was associated with relative gains of 12p and TP53 mutations. The findings in STs with relative gains of 12p suggest that they may exhibit biologic characteristics akin to those seen in germ cell neoplasia in situ ‐related germ cell tumors rather than non‐germ cell neoplasia in situ ‐derived STs. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeminomaTesticular NeoplasmsNeoplasms, Germ Cell and EmbryonalBiological ProductsMaleHumansAgedGenomicsChromosomes, Human, Pair 12

Stichwörter der Autor:innen

GCNISgenomic analysisgerm cell tumori(12p)non-GCNIS-derived germ cell tumorspermatocytic tumortesticular cancertestis

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Pathology, Mayo Clinic, Rochester, MN, USA.
  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Pathology, New York University, New York, NY, USA.
  • Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Pathology, Vanderbilt University, Nashville, TN, USA.
  • Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Matija Snuderl, Andres Martin Acosta

Förderung

  • Department of Pathology of Brigham
  • Women's Hospital and Mayo Clinic

Zitieren

APA

Gupta, S., Sholl, L. M., Yang, Y., Osunkoya, A. O., Gordetsky, J. B., Cornejo, K. M., Michalova, K., Maclean, F., Dvindenko, E., Snuderl, M., Hirsch, M. S., Anderson, W. J., Rowsey, R. A., Jimenez, R. E., Cheville, J. C., Sadow, P. M., Colecchia, M., Ricci, C., Ulbright, T. M., …, & Acosta, A. M. (2024). Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior. The Journal of Pathology. https://doi.org/10.1002/path.6210

Vancouver

Gupta S, Sholl LM, Yang Y, Osunkoya AO, Gordetsky JB, Cornejo KM, et al. Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior. The Journal of Pathology. 2024. doi:10.1002/path.6210

BibTeX
@article{Gupta2024,
  author = {Gupta, Sounak and Sholl, Lynette M and Yang, Yiying and Osunkoya, Adeboye O and Gordetsky, Jennifer B and Cornejo, Kristine M and Michalova, Kvetoslava and Maclean, Fiona and Dvindenko, Eugénia and Snuderl, Matija and Hirsch, Michelle S and Anderson, William J and Rowsey, Ross A and Jimenez, Rafael E and Cheville, John C and Sadow, Peter M and Colecchia, Maurizio and Ricci, Costantino and Ulbright, Thomas M and Berney, Daniel M and Acosta, Andres Martin},
  title = {Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6210}
}
Kostenlos starten →